Seminars in Hematology
Volume 40, Issue 3 , Pages 201-212 , July 2003

Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes

  • Renato Zambello

      Affiliations

    • Department of Clinical and Experimental Medicine, Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
    • ,
  • Gianpietro Semenzato

      Affiliations

    • *Address correspondence to Gianpietro Semenzato, MD, Università degli Studi di Padova, Dip. Medicina Clinica e Sperimentale, Immunologia Clinica, Via Giustiniani 2, Padova 35128, Italy
    • Department of Clinical and Experimental Medicine, Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy

References 

  1. Andre P, Biassoni R, Colonna M, et al.  New nomenclature for MHC receptors. Nat Immunol. 2001;2:661
  2. Aramburu J, Balboa MA, Ramirez A, et al.  A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol. 1990;144:3238–3247
  3. Arase H, Mocarski ES, Campbell AE, et al.  Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002;296:1323–1326
  4. Bahram S. MIC genes: From genetics to biology. Adv Immunol. 2000;76:51–60
  5. Bakker AB, Wu J, Phillips JH, et al.  NK cell activation: Distinct stimulatory pathways counterbalancing inhibitory signals. Hum Immunol. 2000;61:18–27
  6. Bauer S, Groh V, Wu J, et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999;285:727–729
  7. Biassoni R, Cantoni C, Falco M, et al.  The human leukocyte antigen (HLA)-C-specific “activatory” or “inhibitory” natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med. 1996;183:645–650
  8. Bigouret V, Hoffmann T, Arlettaz L, et al.  Monoclonal T cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94-NKG2C/E and NKD2D killer cell receptors. Blood. 2003;101:3158–3204
  9. Borges L, Hsu ML, Fanger N, et al.  A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol. 1997;159:5192–5196
  10. Bottino C, Sivori S, Vitale M, et al.  A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol. 1996;26:1816–1824
  11. Braud V, Jones EY, McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol. 1997;27:1164–1169
  12. Cambiaggi A, Orengo AM, Meazza R, et al.  The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function. Blood. 1996;87:2369–2375
  13. Cantoni C, Biassoni R, Pende D, et al.  The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur J Immunol. 1998;28:327–338
  14. Cantoni C, Bottino C, Augugliaro R, et al.  Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol. 1999;29:3148–3159
  15. Cantoni C, Verdiani S, Falco M, et al.  p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol. 1998;28:1980–1990
  16. Casado LF, Granados E, Algara P, et al.  High expression of the ILT2 (LIR-1) inhibitory receptor for major histocompatibility complex class I molecules on clonal expansions of T large granular lymphocytes in asymptomatic patients. Haematologica. 2001;86:457–463
  17. Chang C, Dietrich J, Harpur AG, et al.  Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties. J Immunol. 1999;163:4651–4654
  18. Chang C, Rodriguez A, Carretero M, et al.  Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol. 1995;25:2433–2437
  19. Colonna M, Navarro F, Bellon T, et al.  A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 1997;186:1809–1818
  20. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 1995;268:405–408
  21. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22:633–640
  22. Cosman D, Mullberg J, Sutherland CL, et al.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 2001;14:123–133
  23. Costello RT, Sivori S, Mallet F, et al.  A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand. Leukemia. 2002;16:855–860
  24. Dohring C, Scheidegger D, Samaridis J, et al.  A human killer inhibitory receptor specific for HLA-A1,2. J Immunol. 1996;156:3098–3101
  25. Falco M, Biassoni R, Bottino C, et al.  Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J Exp Med. 1999;190:793–802
  26. Glienke J, Sobanov Y, Brostjan C, et al.  The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex. Immunogenetics. 1998;48:163–173
  27. Go RS, Li CY, Tefferi A, et al.  Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood. 2001;98:483–485
  28. Go RS, Tefferi A, Li CY, et al.  Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia. Blood. 2000;96:3644–3646
  29. Handgretinger R, Geiselhart A, Moris A, et al.  Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med. 1999;340:278–284
  30. Hoffmann T, De Libero G, Colonna M, et al.  Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type. Br J Haematol. 2000;110:525–536
  31. Houchins JP, Yabe T, McSherry C, et al.  DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med. 1991;173:1017–1020
  32. Kubin MZ, Parshley DL, Din W, et al.  Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48. Eur J Immunol. 1999;29:3466–3477
  33. Lanier LL. NK cell receptors. Annu Rev Immunol. 1998;16:359–393
  34. Lepin EJ, Bastin JM, Allan DS, et al.  Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur J Immunol. 2000;30:3552–3561
  35. Lopez-Botet M, Carretero M, Perez-Villar J, et al.  The CD94/NKG2 C-type lectin receptor complex: Involvement in NK cell- mediated recognition of HLA class I molecules. Immunol Res. 1997;16:175–185
  36. Loughran TPJ. Clonal diseases of large granular lymphocytes. Blood. 1993;82:1–14
  37. Loughran TP, Hadlock KG, Yang Q, et al.  Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3− (natural killer) lymphoproliferative disease of granular lymphocytes. Blood. 1997;90:1977–1981
  38. Martin MP, Nelson G, Lee JH, et al.  Cutting edge: susceptibility to psoriatic arthritis: Influence of activating killer Ig-like receptor genes in the absence of specific HLA- C alleles. J Immunol. 2002;169:2818–2822
  39. Meyaard L, van der Vuurst de Vries AR, de Ruiter T, et al.  The epithelial cellular adhesion molecule (Ep-CAM) is a ligand for the leukocyte-associated immunoglobulin-like receptor (LAIR). J Exp Med. 2001;194:107–112
  40. Mingari MC, Ponte M, Cantoni C, et al.  HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells. Int Immunol. 1997;9:485–491
  41. Mingari MC, Schiavetti F, Ponte M, et al.  Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci USA. 1996;93:12433–12438
  42. Mingari MC, Vitale C, Cambiaggi A, et al.  Cytolytic T lymphocytes displaying natural killer (NK)-like activity: Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol. 1995;7:697–703
  43. Moretta A, Bottino C, Pende D, et al.  Identification of four subsets of human CD3−CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med. 1990;172:1589–1598
  44. Moretta A, Bottino C, Vitale M, et al.  Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol. 1996;14:619–648
  45. Moretta A, Bottino C, Vitale M, et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001;19:197–223
  46. Moretta A, Sivori S, Vitale M, et al.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med. 1995;182:875–884
  47. Moretta A, Vitale M, Bottino C, et al.  P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med. 1993;178:597–604
  48. Moretta L, Bottino C, Cantoni C, et al.  Human natural killer cell function and receptors. Curr Opin Pharmacol. 2001;1:387–391
  49. Nash R, McSweeney P, Zambello R, et al.  Clonal studies of CD3− lymphoproliferative disease of granular lymphocytes. Blood. 1993;81:2363–2368
  50. Olcese L, Cambiaggi A, Semenzato G, et al.  Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol. 1997;158:5083–5086
  51. Pandolfi F, Zambello R, Cafaro A, et al.  Biological and clinical heterogeneity of lymphoproliferative diseases of peripheral mature T-lymphocytes. Lab Invest. 1992;67:224–235
  52. Pascal V, Brunet C, Pradel V, et al.  Analysis of donor NK and T cells infused in patients undergoing MHC-matched allogeneic hematopoietic transplantation. Leukemia. 2002;16:2259–2266
  53. Pende D, Biassoni R, Cantoni C, et al.  The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med. 1996;184:505–518
  54. Pende D, Cantoni C, Rivera P, et al.  Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol. 2001;31:1076–1086
  55. Pende D, Parolini S, Pessino A, et al.  Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med. 1999;190:1505–1516
  56. Pessino A, Sivori S, Bottino C, et al.  Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med. 1998;188:953–960
  57. Phillips JH, Gumperz JE, Parham P, et al.  Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science. 1995;268:403–405
  58. Pietra G, Romagnani C, Falco M, et al.  The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta- mediated recognition. Eur J Immunol. 2001;31:3687–3693
  59. Pietra G, Semino C, Cagnoni F, et al.  Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically. J Med Virol. 2000;62:354–363
  60. Poggi A, Pella N, Morelli L, et al.  p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. Eur J Immunol. 1995;25:369–376
  61. Romagnani C, Pietra G, Falco M, et al.  Identification of HLA-E-specific alloreactive T lymphocytes: A cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc Natl Acad Sci USA. 2002;99:11328–11333
  62. Semenzato G, Pandolfi F, Chisesi T, et al.  The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer. 1987;60:2971–2978
  63. Sivori S, Parolini S, Falco M, et al.  2B4 functions as a co-receptor in human NK cell activation. Eur J Immunol. 2000;30:787–793
  64. Semenzato G, Zambello R, Starkebaum G, et al.  The lymphoproliferative disease of granular lymphocytes. Updated criteria for the diagnosis. Blood. 1997;89:256–260
  65. Sivori S, Vitale M, Morelli L, et al.  p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med. 1997;186:1129–1136
  66. Smith HR, Heusel JW, Mehta IK, et al.  Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA. 2002;99:8826–8831
  67. Sobanov Y, Glienke J, Brostjan C, et al.  Linkage of the NKG2 and CD94 receptor genes to D12S77 in the human natural killer gene complex. Immunogenetics. 1999;49:99–105
  68. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187–376
  69. Vales-Gomez M, Reyburn HT, Erskine RA, et al.  Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 1999;18:4250–4260
  70. Vales-Gomez M, Reyburn HT, Erskine RA, et al.  Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc Natl Acad Sci USA. 1998;95:14326–14331
  71. Vitale M, Bottino C, Sivori S, et al.  NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med. 1998;187:2065–2072
  72. Vitale M, Castriconi R, Parolini S, et al.  The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: Analysis of LIR-1+ NK cell clones. Int Immunol. 1999;11:29–35
  73. Vitale M, Falco M, Castriconi R, et al.  Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol. 2001;31:233–242
  74. Vitale M, Sivori S, Pende D, et al.  Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: Their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci USA. 1996;93:1453–1457
  75. Wagtmann N, Rajagopalan S, Winter CC, et al.  Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity. 1995;3:801–809
  76. Wu J, Song Y, Bakker AB, et al.  An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 1999;285:730–732
  77. Zambello R, Facco M, Trentin L, et al.  Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood. 1997;89:201–211
  78. Zambello R, Loughran TP, Trentin L, et al.  Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes. Leukemia. 1995;9:1207–1211
  79. Zambello R, Loughran TP, Trentin L, et al.  Spontaneous resolution of p58/EB6 antigen restricted NK-type lymphoproliferative disease of granular lymphocytes: Role of Epstein Barr virus infection. Br J Haematol. 1997;99:215–221
  80. Zambello R, Trentin L, Ciccone E, et al.  Phenotypic diversity of natural killer populations in patients with NK-type lymphoproliferative disease of granular lymphocytes. Blood. 1993;81:2381–2385

☆ Supported by grants awarded by Associazione Italiana per la Ricerca sul Cancro (AIRC), CNR, Ministero della Sanità, Ministero dell’Università e della Ricerca Scientifica e Tecnologica (MIUR), and Consiglio Nazionale delle Ricerche.

PII: S0037-1963(03)00134-3

Seminars in Hematology
Volume 40, Issue 3 , Pages 201-212 , July 2003

Article Tools

* Image Usage & Resolution